Enteric illnesses are intestinal infections triggered by a number of bacteria, viruses, and parasites such as salmonella, shigella, Giardia lamblia, campylobacter, cryptosporidium, and vibrio cholerae.
PCR-based Enteric Disease Testing Market: Introduction
- Enteric illnesses are intestinal infections triggered by a number of bacteria, viruses, and parasites such as salmonella, shigella, Giardia lamblia, campylobacter, cryptosporidium, and vibrio cholerae. These enter the body through the mouth or intestinal tract and cause salmonella, shigellosis, giardiasis, campylobacteriosis, cryptosporidiosis, and cholera. Common symptoms of enteric diseases include nausea, vomiting, diarrhea, abdominal cramps, fever, chills, and loss of appetite. Enteric bacteria has been identified as one of the major causative organisms of water and foodborne diseases. Prevalence of hemolytic uremic syndrome and diarrhea (HUS) is increasing across the world. These are mostly caused by enteric bacterial infections.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=69684
PCR-based Enteric Disease Testing Market: Key Trends
- High morbidity and rapid spread of enteric bacterial infection is projected to propel the global PCR-based enteric disease testing market. Prevalence of water and foodborne diseases is rising across the globe, especially in underdeveloped and developing countries. The epidemic of E. coli infection in Germany had spread to various parts of the world (more than 10 countries), including the U.S., the U.K., Spain, and France in 2011. Various environmental as well as clinical samples are tested regularly to identify enteric bacterial infection contamination and take preventive measures, especially during epidemics, in order to stop the spread of infections. Hence, rapid increase of water and foodborne enteric bacterial infection boosts the demand for enteric disease testing across the globe.
Request for Analysis of COVID-19 Impact on PCR-based Enteric Disease Testing Market –
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=69684
Rise in demand for early disease diagnosis is anticipated to boost the growth of the global PCR-based enteric disease testing market. The global burden of enteric disease infection can lead to serious health care problems and even cause deaths. Typhoid salmonellosis, one of the enteric diseases, accounts for 16 million new cases and around 600,000 deaths globally each year. Early detection is the only way to stop the spread of enteric diseases. Traditional culture methods are labor intensive and time consuming. Therefore, these are being replaced by tests able to diagnose illnesses rapidly. These include enzyme immunoassay (EIA), PCR-based tests, and dipstick based tests. Increase in demand for rapid diagnostic tests is a major factor driving the global enteric disease testing market.
- Presently, the world is struggling with the COVID-19 pandemic. COVID-19 leads to pneumonia, severe & acute respiratory disorders, multiple organ failure, and, in severe cases, death. The geriatric population is more prone to COVID-19. Due the pandemic, around 342,000 women were diagnosed with enteric diseases in 2020. The global PCR-based enteric disease testing market witnessed sluggish growth during the pandemic.
- Governments of developing countries are making significant investments to modernize health care infrastructure in their respective countries, which is likely to increase access to health care. This is expected to boost demand for PCR-based enteric disease testing. Rise in prevalence of chronic diseases, especially enteric diseases, in developing countries presents lucrative opportunities in the global PCR-based enteric disease testing market.
Pre book PCR-based Enteric Disease Testing Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=69684<ype=S
North America to Capture Major Share of Global PCR-based Enteric Disease Testing Market
- North America is projected to account for large share of the global PCR-based enteric disease testing market during the forecast period owing to the presence of key companies offering PCR-based enteric disease testing, technological advancements, and increase in number of health care centers. Rise in prevalence of enteric diseases among the population fuels the growth of the market in the region.
- The PCR-based enteric disease testing market in Europe is likely to grow at a rapid pace during the forecast period led by increase in research & development. The PCR-based enteric disease testing market in Asia Pacific is projected to expand at a high CAGR during the forecast period due to rise in prevalence of enteric diseases and increase in awareness.
For More Information :
https://www.transparencymarketresearch.com/pcr-based-enteric-disease-testing-market.html
Key Players Operating in Global PCR-based Enteric Disease Testing Market
Leading players hold major share in their respective regions. Growth strategies adopted by leading players are likely to drive the global PCR-based enteric disease testing market.
Major players operating in the global PCR-based enteric disease testing market are:
- Bio-Rad Laboratories, Inc.
- bioMérieux SA
- Thermo Fisher Scientific Inc.
- Vela Diagnostics
- Coris BioConcept
- Meridian Life Science, Inc.
- Bio-Rad Laboratories, Inc.
- Abbott
- Trinity Biotech
- DiaSorin Molecular LLC
- Other Prominent Players
Browse more Market Reports:
Diagnostic Imaging Services Market:
Imaging service plays crucial role in medical field. It is used for prompt diagnosis of any medical condition, monitoring medical condition at the time of treatment, and also as a part of preventive measures. Rising awareness among consumers regarding early detection of disease is providing lucrative growth opportunities.
With the increasing growth of the healthcare industry, healthcare organizations and professionals have shifted to value-based business models. Improving surgical outcome is taking center stage in new experience-driven business models of the industry, and postoperative care has attracted the attention of healthcare professionals.
Structural Heart Devices Market:
Structural heart devices technology has seen a paradigm shift with the advent of non-invasive procedures to treat aortic stenosis and mitral regurgitation. From a previously sluggish approach, there seems to be a spate of activity characterized by investor excitement and massive research & development (R&D) initiatives regarding minimally-invasive heart valve technologies. For cardio-thoracic surgeons and interventional cardiologists, this arena offers tremendous scope and potential vis-à-vis traditional open heart surgery that is associated with severe side-effects.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453